These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1381012)

  • 41. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.
    Greve AM; Olsen MH; Bella JN; Lønnebakken MT; Gerdts E; Okin PM; Palmieri V; Boman K; Nieminen MS; Omvik P; Dahlöf B; Devereux RB; Wachtell K
    Am J Hypertens; 2012 Sep; 25(9):1017-23. PubMed ID: 22695506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of lisinopril versus atenolol for mild to moderate essential hypertension.
    Beevers DG; Blackwood RA; Garnham S; Watson M; Mehrzad AA; Admani K; Angell-James JE; Feely M; Kumar S; Husaini MH
    Am J Cardiol; 1991 Jan; 67(1):59-62. PubMed ID: 1846057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of the effects of lisinopril when used in addition to atenolol.
    Soininen K; Gerlin-Piira L; Suihkonen J; Kyllönen T; Parviainen R; Kyllönen E; Hämäläinen K; Lonka R; Tikkanen T; Selonen R
    J Hum Hypertens; 1992 Aug; 6(4):321-4. PubMed ID: 1331443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bepridil improves left ventricular performance in patients with angina pectoris.
    Zusman RM; Higgins J; Christensen D; Boucher CA
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):474-80. PubMed ID: 7504141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
    Otterstad JE; Erikssen J; Froeland G; Soeyland AK; Saltvedt E
    Blood Press; 1992 Dec; 1(4):212-8. PubMed ID: 1345218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of atenolol on left ventricular function in hypertensive patients.
    Ibrahim MM; Madkour MA; Mossallam R
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():473s-475s. PubMed ID: 7449301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac effects of ACE inhibition.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S36-40. PubMed ID: 7507538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemodynamic comparison of amlodipine and atenolol in essential hypertension using the quantascope.
    Tham TC; Herity N; Guy S; Silke B
    Br J Clin Pharmacol; 1993 Dec; 36(6):555-60. PubMed ID: 12959272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin-converting enzyme inhibitors: more different than alike? Focus on cardiac performance.
    Zusman RM
    Am J Cardiol; 1993 Dec; 72(20):25H-36H. PubMed ID: 8285179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of exercise and therapy on ventricular emptying and filling in mildly hypertensive patients.
    Clements IP; Bailey KR; Zachariah PK
    Am J Hypertens; 1994 Aug; 7(8):695-702. PubMed ID: 7986459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of antihypertensive therapies by noninvasive techniques.
    Graettinger WF; Lipson JL; Klein RC; Cheung DG; Weber MA
    Chest; 1989 Jul; 96(1):74-9. PubMed ID: 2544352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.
    Wachtell K; Bella JN; Rokkedal J; Palmieri V; Papademetriou V; Dahlöf B; Aalto T; Gerdts E; Devereux RB
    Circulation; 2002 Mar; 105(9):1071-6. PubMed ID: 11877357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
    Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of chronic atenolol therapy on cardiovascular response to isometric exercise in essential hypertension.
    Kobayashi Y; Kuniyoshi K; Miyata H; Kawata S; Kajiwara N
    J Int Med Res; 1989; 17(2):125-31. PubMed ID: 2721812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.